ENTA · Enanta Pharmaceuticals Inc
$12.45
-0.16 (-1.27%)
At close · Jul 29
Market Cap
$362.03M
Shares
29.08M
Notices of intent to sell restricted or control shares, filed with the SEC on Form 144 by insiders and affiliates. A Form 144 signals a planned sale — it does not confirm the shares were actually sold.
| Filed | Seller | Relationship | Shares | Approx. Sale | Broker |
|---|---|---|---|---|---|
| 2025-12-05 | Luly Jay R. | Officer, Director | 4,743 | 2025-12-05 | Morgan Stanley Smith Barney |
| 2024-07-11 | Scott T. Rottinghaus | Officer | 11,945 | 2024-07-11 | J.P. Morgan Securities LLC |
| 2024-06-17 | Tara Lynn Kieffer | Officer | 7,266 | 2024-06-17 | J.P. Morgan Securities LLC |
| 2023-12-12 | Vance Terry | Director | 15,295 | 2023-12-13 | Pershing LLC |
Showing 1–4 of 4 filings
Key facts
CIK
1177648
CUSIP
29251M106
13F (30d)
40 filings
19 filers
Visit website
Investor relations